Aura Biosciences, Inc.
NASDAQ:AURA
8.2 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -76.408 | -58.763 | -35.251 | -22.206 | -24.2 |
Depreciation & Amortization
| 1.295 | 1.177 | 0.831 | 0.831 | 0.509 |
Deferred Income Tax
| 0 | 0 | 0.014 | 0 | 0.011 |
Stock Based Compensation
| 8.772 | 6.412 | 2.307 | 0.736 | 0.507 |
Change In Working Capital
| 4.441 | -3.102 | -0.315 | -3.679 | 2.464 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| -1.04 | 0.34 | 1.054 | -1.721 | 1.043 |
Other Working Capital
| 5.481 | -3.442 | -1.369 | -1.958 | 1.421 |
Other Non Cash Items
| -1.947 | -0.325 | 0.004 | -0.003 | 0.043 |
Operating Cash Flow
| -63.847 | -54.601 | -32.41 | -24.321 | -20.666 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -0.709 | -1.094 | -2.125 | -0.771 | -2.221 |
Acquisitions Net
| 0 | 0.067 | 0 | 0 | 0 |
Purchases Of Investments
| -233.651 | -119.784 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 120.397 | 53.009 | 0 | 0 | 0 |
Other Investing Activites
| 0 | -0.067 | 0 | 0 | 0 |
Investing Cash Flow
| -113.963 | -67.869 | -2.125 | -0.771 | -2.221 |
Financing Activities: | |||||
Debt Repayment
| 0 | 0 | 0 | 0 | -0.037 |
Common Stock Issued
| 3.17 | 8.549 | 78.697 | 10.07 | 39.763 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | -0.013 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 94.12 | 87.08 | 87.562 | 19.943 | 39.763 |
Financing Cash Flow
| 97.29 | 95.629 | 166.259 | 10.036 | 39.726 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -80.52 | -26.841 | 131.724 | -15.056 | 16.839 |
Cash At End Of Period
| 41.85 | 122.37 | 149.211 | 17.487 | 32.543 |